By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Mural Oncology plc

Mural Oncology plc (MURA)

NASDAQ Currency in USD
$2.07
$0.00
0.00%
Last Update: 11 Sept 2025, 20:00
$35.86M
Market Cap
-0.24
P/E Ratio (TTM)
Forward Dividend Yield
$0.95 - $4.74
52 Week Range

MURA Stock Price Chart

Explore Mural Oncology plc interactive price chart. Choose custom timeframes to analyze MURA price movements and trends.

MURA Company Profile

Discover essential business fundamentals and corporate details for Mural Oncology plc (MURA) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

16 Nov 2023

Employees

116.00

CEO

Caroline J. Loew

Description

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.

MURA Financial Timeline

Browse a chronological timeline of Mural Oncology plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 12 Nov 2025

EPS estimate is -$0.59.

Earnings released on 4 Aug 2025

EPS came in at -$1.77 falling short of the estimated -$1.13 by -56.64%.

Earnings released on 14 May 2025

EPS came in at -$1.93 surpassing the estimated -$2.12 by +8.96%.

Earnings released on 11 Mar 2025

EPS came in at -$2.01 falling short of the estimated -$1.98 by -1.52%, while revenue for the quarter reached $3.49M .

Earnings released on 13 Nov 2024

EPS came in at -$1.87 surpassing the estimated -$1.96 by +4.59%.

Earnings released on 13 Aug 2024

EPS came in at -$1.86 surpassing the estimated -$1.90 by +2.11%.

Earnings released on 14 May 2024

EPS came in at -$1.84 surpassing the estimated -$2.66 by +30.83%.

Earnings released on 26 Mar 2024

EPS came in at -$3.57 , while revenue for the quarter reached $2.62M .

Earnings released on 14 Dec 2023

EPS came in at -$3.07 .

Earnings released on 30 Jun 2023

EPS came in at -$3.13 .

Earnings released on 31 Mar 2023

EPS came in at -$2.78 .

Earnings released on 31 Dec 2022

EPS came in at -$3.52 .

Earnings released on 30 Sept 2022

EPS came in at -$3.03 .

MURA Stock Performance

Access detailed MURA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run